XWELL, Inc. (XWEL)
NASDAQ: XWEL · Real-Time Price · USD
1.060
+0.020 (1.92%)
At close: Jun 26, 2026, 4:00 PM EDT
1.130
+0.070 (6.60%)
After-hours: Jun 26, 2026, 4:48 PM EDT

Company Description

XWELL, Inc. engages in the provision of health and wellness services to travelers in the United States and internationally.

It operates in three segments: XpresSpa, XpresTest, and Naples Wax Center. The XpresSpa segment provides traveler’s spa services, including massage, and nail and skin care services, as well as spa and travel products.

The XpresTest segment offers COVID-19 and other medical testing to the traveling public, as well as airline, airport and concessionaire employees, and TSA and U.S. customs and border protection agents; aircraft wastewater and passenger nasal sampling through the CDC’s bio-surveillance program; and various services and support, including technical support services and advanced services.

The Napple Wax Center segment offers skincare and cometic products, as well as face and body waxing services.

It offers its services through stores and kiosks, as well as online. The company was formerly known as XpresSpa Group, Inc. and changed its name to XWELL, Inc. in October 2022.

XWELL, Inc. is based in New York, New York.

XWELL, Inc.
XWELL logo
Country United States
Founded 2006
Industry Diagnostics & Research
Sector Healthcare
Employees 280
CEO Ezra Ernst

Contact Details

Address:
254 West 31st Street, 11th Floor
New York, New York 10001
United States
Phone 212 750 9595
Website xwell.com

Stock Details

Ticker Symbol XWEL
Exchange NASDAQ
Stock Type Common Stock
Fiscal Year January - December
Reporting Currency USD
CIK Code 0001410428
CUSIP Number 98420U802
ISIN Number US98420U8027
SIC Code 7200

Key Executives

Name Position
Ezra T. Ernst President, Chief Executive Officer and Director
Thomas Ian Brown Chief Financial Officer
Patti Ward Chief Operating Officer
Mike Heronime Marketing Director
Peter Vermeulen Head of Human Resources

Latest SEC Filings

Date Type Title
Jun 11, 2026 SCHEDULE 13G Filing
May 20, 2026 10-Q Quarterly Report
May 15, 2026 NT 10-Q Notification of inability to timely file Form 10-Q or 10-QSB
Apr 30, 2026 10-K/A [Amend] Annual report
Apr 16, 2026 424B3 Prospectus
Apr 15, 2026 EFFECT Notice of Effectiveness
Apr 13, 2026 UPLOAD Filing
Apr 10, 2026 8-K/A [Amend] Current report
Apr 1, 2026 S-3 Registration statement under Securities Act of 1933
Apr 1, 2026 8-K Current Report